Agile Therapeutics reported $3M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Adma Biologics ADMA:US USD 41.09M 7.18M
Agile Therapeutics AGRX:US USD 3M 876K
Bayer BAYN:GR EUR 11.28B 1.54B
Biomarin Pharmaceutical BMRN:US USD 505.34M 28.45M
JAZZ PHA JAZZ:US USD 940.65M 7.77M
Johnson & Johnson JNJ:US USD 23.71B 85M
Merk MRK:US USD 14.96B 366M
Pacira Pharmaceuticals PCRX:US USD 167.47M 1.94M
Pfizer PFE:US USD 24.29B 1.65B
Teva Pharmaceutical Industries TEVA:US USD 3.6B 191M
Therapeuticsmd TXMD:US USD 20.92M 7.64M